Early data shows Novartis' experimental radiopharma drug reduces tumor markers in patients with advanced prostate cancer Novartis says 40% of cancer R&D investments going toward radiopharma therapies ...

A previous trial involving patients with metastatic prostate cancer that was resistant to androgen pathway modulation (formerly referred to as castration-resistant) showed that adding talazoparib ...

Prostate cancer specialists oppose plans to restrict screening to only a few thousand men, research has shown.

Pfizer appears to have one-upped Johnson & Johnson again in their PARP inhibitor battle in prostate cancer. After winning a broader FDA label in metastatic castration-resistant prostate cancer (mCRPC) ...

The former first lady said it was 'shocking' when her husband, former President Joe Biden, was diagnosed with cancer last year, less than six months after leaving the White House ...

Former first lady Jill Biden opened up about her husband’s battle with prostate cancer in a new interview. She said in a ...

Only men with a dangerous genetic variant and a family history of cancer should be offered screening, say UK advisors.

Only "a few thousand" men who have a dangerous genetic variant and a family history of cancer should be screened, experts say ...

The National Screening Committee said attempting to detect the disease using the specific antigen blood test was 'likely to ...

The majority of men in the UK will not be offered prostate cancer screening following a final recommendation from a committee ...

UK experts have recommended that only a small group of high-risk men should be eligible for regular testing for prostate ...

Majority of men in UK will not be offered routine prostate cancer screening - Black men have double the risk of prostate ...